Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 99

1.

Blood presence of circulating oncofetal fibronectin mRNA, by RT-PCR, does not represent a useful specific marker for the management and follow-up of thyroid cancer patients.

Vendittelli F, Raffaelli M, Fadda G, Carelli-Alinovi C, Paolillo C, Bellantone R, Zuppi C, Capoluongo E.

Clin Chem Lab Med. 2012 Jan 6;50(4):715-20. doi: 10.1515/cclm-2011-0848.

PMID:
22505562
2.

Oncofoetal fibronectin--a tumour-specific marker in detecting minimal residual disease in differentiated thyroid carcinoma.

Hesse E, Musholt PB, Potter E, Petrich T, Wehmeier M, von Wasielewski R, Lichtinghagen R, Musholt TJ.

Br J Cancer. 2005 Sep 5;93(5):565-70.

3.

Galectin-3 and oncofetal-fibronectin expression in thyroid neoplasia as assessed by reverse transcription-polymerase chain reaction and immunochemistry in cytologic and pathologic specimens.

Giannini R, Faviana P, Cavinato T, Elisei R, Pacini F, Berti P, Fontanini G, Ugolini C, Camacci T, De Ieso K, Miccoli P, Pinchera A, Basolo F.

Thyroid. 2003 Aug;13(8):765-70.

PMID:
14558920
4.

Serum oncofetal fibronectin (onfFN) mRNA in differentiated thyroid carcinoma (DTC): large overlap between disease-free and metastatic patients.

Sritara C, Charoenphun P, Ponglikitmongkol M, Musikarat S, Utamakul C, Chokesuwattanasakul P, Thakkinstian A.

Asian Pac J Cancer Prev. 2012;13(8):4203-8.

5.

Oncofetal fibronectin mRNA is highly abundant in the blood of patients with papillary thyroid carcinoma and correlates with high-serum thyroid-stimulating hormone levels.

Wehmeier M, Petrich T, Brand K, Lichtinghagen R, Hesse E.

Thyroid. 2010 Jun;20(6):607-13. doi: 10.1089/thy.2009.0332.

PMID:
20470202
6.
7.
8.

Blood thyroglobulin and TSH receptor mRNA detection by RT-PCR in the follow-up of differentiated thyroid cancer patients.

Torosian L, Manrique G, Alvarez B, Lago G, Roca R, Belzarena C.

Rev Esp Med Nucl. 2010 May-Jun;29(3):109-13. doi: 10.1016/j.remn.2009.12.010.

9.

Expression of oncofetal fibronectin mRNA in thyroid anaplastic carcinoma.

Takano T, Ito Y, Matsuzuka F, Miya A, Kobayashi K, Yoshida H, Miyauchi A.

Jpn J Clin Oncol. 2007 Sep;37(9):647-51. Epub 2007 Aug 18.

PMID:
17704536
10.

Detection of circulating Tg-mRNA in the follow-up of papillary and follicular thyroid cancer: how useful is it?

Verburg FA, Lips CJ, Lentjes EG, de Klerk JM.

Br J Cancer. 2004 Jul 19;91(2):200-4. Review.

11.
12.

Molecular detection of thyroglobulin mRNA transcripts in peripheral blood of patients with thyroid disease by RT-PCR.

Bojunga J, Röddiger S, Stanisch M, Kusterer K, Kurek R, Renneberg H, Adams S, Lindhorst E, Usadel KH, Schumm-Draeger PM.

Br J Cancer. 2000 May;82(10):1650-5.

13.

Evaluation of quantitative measurement of thyroglobulin mRNA in the follow-up of differentiated thyroid cancer.

Denizot A, Delfino C, Dutour-Meyer A, Fina F, Ouafik L.

Thyroid. 2003 Sep;13(9):867-72.

PMID:
14588101
14.
15.

Measurement of thyroglobulin mRNA in peripheral blood as an adjunctive test for monitoring thyroid cancer.

Grammatopoulos D, Elliott Y, Smith SC, Brown I, Grieve RJ, Hillhouse EW, Levine MA, Ringel MD.

Mol Pathol. 2003 Jun;56(3):162-6.

16.
17.

[Aspiration biopsy-RT-PCR(ABRP): lesson from its success].

Takano T, Amino N.

Rinsho Byori. 2001 Dec;49(12):1248-54. Review. Japanese.

PMID:
11797396
18.

Development of a sensitive and specific quantitative reverse transcription-polymerase chain reaction assay for blood thyroglobulin messenger ribonucleic acid in the follow-up of patients with differentiated thyroid carcinoma.

Boldarine VT, Maciel RM, Guimarães GS, Nakabashi CC, Camacho CP, Andreoni DM, Mamone Mda C, Ikejiri ES, Kasamatsu TS, Crispim F, Hojaij FC, Hidal JT, Biscolla RP.

J Clin Endocrinol Metab. 2010 Apr;95(4):1726-33. doi: 10.1210/jc.2009-1354. Epub 2010 Feb 19.

PMID:
20173019
19.

Low specificity of blood thyroglobulin messenger ribonucleic acid assay prevents its use in the follow-up of differentiated thyroid cancer patients.

Elisei R, Vivaldi A, Agate L, Molinaro E, Nencetti C, Grasso L, Pinchera A, Pacini F.

J Clin Endocrinol Metab. 2004 Jan;89(1):33-9.

PMID:
14715824
20.

Thyrotropin receptor/thyroglobulin messenger ribonucleic acid in peripheral blood and fine-needle aspiration cytology: diagnostic synergy for detecting thyroid cancer.

Wagner K, Arciaga R, Siperstein A, Milas M, Warshawsky I, Sethu S, Reddy K, Gupta MK.

J Clin Endocrinol Metab. 2005 Apr;90(4):1921-4. Epub 2005 Feb 1.

PMID:
15687333

Supplemental Content

Support Center